Antimetabolite Therapy for Uveitis: Methotrexate or Mycophenolate?

JAMA Ophthalmol. 2019 Dec 1;137(12):1449-1451. doi: 10.1001/jamaophthalmol.2019.3964.

Author

Douglas A Jabs^{1

2}

Affiliations

¹ Center for Clinical Trials and Evidence Synthesis, Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland.
² Wilmer Eye Institute, Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

PMID: 31503274
DOI: 10.1001/jamaophthalmol.2019.3964

No abstract available

Publication types

Comment

MeSH terms

Adrenal Cortex Hormones
Antimetabolites / therapeutic use
Humans
Immunosuppressive Agents / therapeutic use
Inflammation
Methotrexate / therapeutic use
Mycophenolic Acid* / therapeutic use
Uveitis* / drug therapy

Substances

Adrenal Cortex Hormones
Antimetabolites
Immunosuppressive Agents
Mycophenolic Acid
Methotrexate